Cancer care has progressed leaps and bounds in the last 20 years, driven by advancements in genomics and diagnostics. Despite these advances, cancer remains a growing global threat, accounting for nearly one in six deaths worldwide. 

Simranjit Singh is pioneering change in the field of cancer diagnostics. As the CEO of Guardant Health AMEA, he’s on a mission to provide reliable and accessible tests to improve patient outcomes and reduce the burden of the disease.

In this episode, Simranjit chats with hosts Charan Siingh and Richard Bleasdale about the challenges of driving adoption of new healthcare technologies as he strives towards Conquering Cancer.

Don't miss any episode, follow us on @transformasians.podcast now!